Official Louisiana State Websites use .la.gov 
Secure .gov websites use HTTPS 
LDH News
-
-
Second Oversight Report: Molluscan Shellfish
-
Second Oversight Report: Consumable Hemp Potpourri
-
Second Oversight Report: Newborn Screening
Second Oversight Report for the proposed additions to the Newborn Screening Panel
-
Second Oversight Report: Consumable Hemp Products
Second oversight report for the proposed Consumable Hemp Products rule to be published in February 2022.
-
First Oversight Report: Newborn Screening
First oversight for proposed rule to include Spinal Muscular Atrophy (SMA), Mucopolysaccharidosis (MPS I), and Glycogen Storage Diseases Type II (Pompe Disease) to the Louisiana Newborn Screening Panel.
-
SECOND OVERSIGHT REPORT: Proposed Immunization Schedule
In accordance with R.S. 49:968, the 2nd Legislative Oversight Committee Report for the proposed Immunization Schedule rule has been submitted to the applicable oversight committees.
-
FIRST OVERSIGHT REPORT: Proposed Immunization Schedule
In accordance with R.S. 49:968, the 1st Legislative Oversight Committee Report for the proposed Immunization Schedule rule has been submitted to the applicable oversight committees.
-
SECOND OVERSIGHT REPORT: Industrial Hemp-Derived Cannabidiol Products Registration
In accordance with R.S. 49:968, the 2nd Legislative Oversight Committee Report for the Industrial Hemp-Derived Cannabidiol Products Registration rule has been submitted to the applicable oversight committees.
-
FIRST OVERSIGHT REPORT: Mandatory Tuberculosis Testing Revisions
This proposed rule eliminates the current requirement for annual TB testing for most employees, students or volunteers at any medical or 24-hour residential facility requiring licensing by the Louisiana Department of Health (LDH), or at any LDH-OPH parish health unit or an LDH-OPH out-patient health care facility.
-
FIRST OVERSIGHT REPORT: Automated External Defibrillators
Under the authority of R.S. 36:254(B)(7) and in accordance with R.S. 49:950 et seq., the Administrative Procedure Act, notice is hereby given that the Louisiana Department of Health, Office of Public Health (LDH-OPH) intends to amend Chapter 61 (Automated External Defibrillators) of Subpart 3 (Licensing and Certification) of Part I (General Administration) of Title 48 (Public Health—General) of the Louisiana Administrative Code (LAC). The proposed amendments are necessary to update the LAC to match the amended R.S. 40:1137.3.
-
FIRST OVERSIGHT REPORT: Industrial Hemp-Derived Cannabidiol Products Registration
In accordance with R.S. 49:968, the 1st Legislative Oversight Committee Report for the proposed Industrial Hemp-Derived Cannabidiol Products Registration rule has been submitted to the applicable oversight committees.